T CELL THERAPY MEETS METABOLOMICS WITH TEGs

The innovation of αβT cells engineered to Express a defined γδT cell receptor (TEG) has strong therapeutic potential for combating and eradicating cancer

NEWS

THE SCIENCE

TEGs have strong therapeutic potential for combatting and eradicating both hematological and solid tumors. This approach combines high-affinity γδT cell receptors (TCRs) with αβT cells utilizing their superior proliferation capacity.

EXECUTIVE TEAM

COO

CEO

CBO

Mark Throsby

CSO